#ivf equipment manufacturers

[merckindiasposts]

Discover cutting-edge IVF equipment solutions tailored to revolutionize fertility treatments with Merck, a pioneering life science company at the forefront of innovation in reproductive technology

[hospitalequipment]

The most shared reasons for feminine infertility are problems with ovulation, cervix problem, and injury to the fallopian tube or uterus.This blog talks about the imperative equipment for IVF labs that are made by IVF equipment Manufacturers.

[healthcare-domain]

Infertility Treatment Market Scope of Current and Future, Key Players Analysis by 2026

According to the new market research report "Infertility Treatment Market by Product (Equipment, Media, Accessories), Procedure (ART (IVF,ICSI, Surrogate), Insemination, Laparoscopy, Hysteroscopy, Patient Type (Female, Male), End User (Fertility Clinics, Hospitals, Research) - Global Forecast to 2026", published by MarketsandMarkets™, the global Infertility Treatment Market size is projected to reach USD 2.2 billion by 2026 from USD 1.5 billion in 2021, at a CAGR of 8.1% during the forecast period.

Browse in-depth TOC on "Infertility Treatment Market"

215 – Tables 40 – Figures 255 – Pages

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=43497112

The decline in the fertility rate, increase awareness about the availability of infertility treatment procedures, rising number of fertility clinics, increasing public & private investments and growing technological advancements are expected to drive market growth in the coming years

The infertility treatment market include major Tier I and II suppliers of infertility treatment equipment, media & consumables are The Cooper Companies Inc. (US), Cook Group (US), Vitrolife (Sweden), Thermo Fisher Scientific, Inc. (US), Esco Micro Pte. Ltd. (Singapore), Genea Biomedx (Australia), IVFtech ApS (Denmark), FUJIFILM Irvine Scientific (US), The Baker Company, Inc. (US), Kitazato Corporation (Japan), Rocket Medical plc (UK), IHMedical A/S (Denmark), Hamilton Thorne Ltd. (US), ZEISS Group (Germany), MedGyn Products, Inc. (US), DxNow, Inc. (US), Nidacon International AB (Sweden), Gynotec B.V. (Netherlands), SAR Healthline Pvt. Ltd. (India), and InVitroCare Inc. (US). These suppliers have their manufacturing facilities spread across regions such as North America, Europe, Asia Pacific.

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=43497112

COVID-19 has impacted their businesses as well. Logistical issues, managing patients with the disease, prioritizing patients with comorbidities and pre-existing conditions, and protecting public & hospital frontline workers from exposure to the COVID-19 infection are the major challenges faced by healthcare systems across the globe. One in six reproductive-aged couples experiences infertility, and many turn to treatments such as intrauterine insemination (IUI) and in vitro fertilization (IVF), which require in-person appointments to complete.

The fertility rate worldwide is declining steadily owing to various factors, such as the growing trend of late marriages and increasing age-related infertility. Global fertility rates are projected to decline to 2.4 children per woman by 2030 and 2.2 children per woman by 2050. This declining fertility rate has led to a significant increase in the demand for infertility treatment products that determine the fertility window in males and females.

The rise in number of fertility clinics to support the market growth during the forecast period.

Significant rise in number of fertility clinics, coupled with the decline in the fertility rate across the globe. Along with this growing focus of players and government towards the launching and acquiring new fertility centers across the globe is likely to contribute towards the growth of the segment. The expansion of fertility clinics equipped with advanced technology is anticipated to increase the accessibility of infertility treatment devices among infertile couples.

Speak to Analyst: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=43497112

Asia Pacific likely to emerge as the fastest-growing infertility treatment market, globally

Geographically, the emerging Asian countries, such as China, India, Japan and Singapore, are offering high-growth opportunities for market players. The Asia Pacific point of care market is projected to grow at the highest CAGR of 9.1% from 2021 to 2026. Expansion of healthcare infrastructure and increase in disposable personal income, rising medical tourism in Asian countries, increasing healthcare expenditure, and growing awareness among people about infertility are supporting the growth of the infertility treatment market in the region.

Prominent players in this market are The Cooper Companies Inc. (US), Cook Group (US), Vitrolife (Sweden), Thermo Fisher Scientific, Inc. (US), FUJIFILM Irvine Scientific (US), Kitazato Corporation (Japan), and Hamilton Thorne Ltd. (US), among others

[tamanna31]

Biopreservation Market by Regions, Type & Applications During 2023-2030

Biopreservation Market Size & Trends

The global biopreservation market size was valued at USD 2.18 billion in 2022 and is projected to grow at a compound annual growth rate (CAGR) of 28.30% from 2023 to 2030. 

Biopreservation is experiencing growth due to various factors such as extensive usage in hospitals and labs, rising funding assistance from government and private partners in healthcare, an upsurge in research & development, and growing advancement in terms of product development. For example, in April 2021, BioLife Solutions launched a new high-capacity controlled freezer to cater to the cell and gene therapy market, which helped the company expand its existing product portfolio. The market experienced a major hindrance during the COVID-19 pandemic with supply chain issues, unavailability of raw materials, and hindrances in research activities among other reasons. However, the pandemic also accelerated the growth of novel biologics, and vaccine technologies. Due to these factors, opportunities for biologics manufacturing and preservation are anticipated to increase, thus generating further demand for biopreservation.

Gather more insights about the market drivers, restrains and growth of the Biopreservation Market 

Biopreservation is a process that helps maintain the integrity and functionality of biological products such as stem cells, DNA, tissues, and organs under different temperatures, thereby prolonging their lifespan outside their natural environment. Technology innovations include microarrays or incorporation of a wide range of predictive models, such as hybrid models, and various API algorithms which help reduce the time, cost and complexity of the overall process. Furthermore, the advent of multiplex cellular imaging platforms is anticipated to enhance the biopreservation ability to help understand disease progression and suggest suitable diagnostic & treatment measures to follow, specifically for cardiology, gynecology, and point-of-care applications.

In recent years, there has been an upsurge in demand for use of biopreservation to develop biological products in R&D of various sectors such as immunotherapies, vaccine production, antibody production, enzyme technology, and biologically produced chemicals. This impact is due to the rising number of chronic disease incidences globally. For instance, according to the Centers for Disease Control and Prevention, cardiovascular disorders and cancer are among the leading causes of disease-related mortality in adults in the U.S.  

Furthermore, the government and private sectors have shown interest and supported funding activities in research & development, leading to immense market developments. In recent years, the growing demand for preserving stem cells and developing biological medicines and products has gained investors' focus in this field. This considerable healthcare spending is expected to fuel market growth during the forecast period.

However, the growing biopreservation market is associated with challenges such as the unavailability of skilled professionals and the lack of stringent cybersecurity measures. The high cost of labor training and software standardization are some of the contributing factors. These challenges could potentially impact overall market growth.

Biopreservation Market Segmentation

Grand View Research has segmented the global biopreservation market report on the basis of product, application, and region:

Product Outlook (Revenue, USD Billion, 2018 - 2030)

Equipment

Freezers

Refrigerators

Consumables

Vials

Straws

Microtiter Plates

Bags

Liquid Nitrogen

Media

Pre-formulated

Home-brew

Laboratory Information Management System (LIMS)

Application Outlook (Revenue, USD Billion, 2018 - 2030)

Regenerative Medicine

Cell Therapy

Gene Therapy

Others

Bio-banking

Human Eggs

Human Sperms

Veterinary IVF

Drug Discovery

Regional Outlook (Revenue, USD Billion, 2018 - 2030)

North America

US

Canada

Europe

Germany

UK

France

Italy

Spain

Denmark

Sweden

Norway

Asia Pacific

China

Japan

India

Australia

Thailand

South Korea

Latin America

Brazil

Mexico

Argentina

Middle East and Africa (MEA)

South Africa

Saudi Arabia

UAE

Kuwait

Browse through Grand View Research's Biotechnology Industry Research Reports.

The global optical genome mapping market size was valued at USD 104.1 million in 2023 and is expected to grow at a CAGR of 26.76% from 2024 to 2030. 

The global therapeutic drug monitoring market size was valued USD 1.80 billion in 2023 and is projected to grow at a CAGR of 3.8% from 2024 to 2030. 

Key Companies & Market Share Insights

Key players in the market are opting for strategic initiatives, funding facilities for geographical expansion, partnerships, mergers and acquisitions in key regions. For instance, in January 2023, the Hamad Medical Corporation and Qatar BioBank launched a new tissue biobank service in Qatar to provide researchers the access to high-quality tissue samples. Some of the key players in the biopreservation market include:

Azenta US, Inc.

Biomatrica, Inc.

BioLife Solutions

MVE Biological Solutions

LabVantage Solutions, Inc.

Taylor-Wharton.

Thermo Fisher Scientific, Inc.

Panasonic Corporation

X-Therma Inc.

PrincetonCryo.

Stirling Ultracold 

Order a free sample PDF of the Biopreservation Market Intelligence Study, published by Grand View Research.

[industrynewsupdates]

Biopreservation Market Size, Share, Growth Analysis And Forecast, 2030

The global biopreservation market size was valued at USD 2.18 billion in 2022 and is projected to grow at a compound annual growth rate (CAGR) of 28.30% from 2023 to 2030. 

Biopreservation is experiencing growth due to various factors such as extensive usage in hospitals and labs, rising funding assistance from government and private partners in healthcare, an upsurge in research & development, and growing advancement in terms of product development. For example, in April 2021, BioLife Solutions launched a new high-capacity controlled freezer to cater to the cell and gene therapy market, which helped the company expand its existing product portfolio. The market experienced a major hindrance during the COVID-19 pandemic with supply chain issues, unavailability of raw materials, and hindrances in research activities among other reasons. However, the pandemic also accelerated the growth of novel biologics, and vaccine technologies. Due to these factors, opportunities for biologics manufacturing and preservation are anticipated to increase, thus generating further demand for biopreservation.

Gather more insights about the market drivers, restrains and growth of the Biopreservation Market 

Biopreservation is a process that helps maintain the integrity and functionality of biological products such as stem cells, DNA, tissues, and organs under different temperatures, thereby prolonging their lifespan outside their natural environment. Technology innovations include microarrays or incorporation of a wide range of predictive models, such as hybrid models, and various API algorithms which help reduce the time, cost and complexity of the overall process. Furthermore, the advent of multiplex cellular imaging platforms is anticipated to enhance the biopreservation ability to help understand disease progression and suggest suitable diagnostic & treatment measures to follow, specifically for cardiology, gynecology, and point-of-care applications.

In recent years, there has been an upsurge in demand for use of biopreservation to develop biological products in R&D of various sectors such as immunotherapies, vaccine production, antibody production, enzyme technology, and biologically produced chemicals. This impact is due to the rising number of chronic disease incidences globally. For instance, according to the Centers for Disease Control and Prevention, cardiovascular disorders and cancer are among the leading causes of disease-related mortality in adults in the U.S.  

Furthermore, the government and private sectors have shown interest and supported funding activities in research & development, leading to immense market developments. In recent years, the growing demand for preserving stem cells and developing biological medicines and products has gained investors' focus in this field. This considerable healthcare spending is expected to fuel market growth during the forecast period.

However, the growing biopreservation market is associated with challenges such as the unavailability of skilled professionals and the lack of stringent cybersecurity measures. The high cost of labor training and software standardization are some of the contributing factors. These challenges could potentially impact overall market growth.

Biopreservation Market Segmentation

Grand View Research has segmented the global biopreservation market report on the basis of product, application, and region:

Product Outlook (Revenue, USD Billion, 2018 - 2030)

• Equipment

o Freezers

o Refrigerators

o Consumables

o Vials

o Straws

o Microtiter Plates

o Bags

o Liquid Nitrogen

• Media

o Pre-formulated

o Home-brew

• Laboratory Information Management System (LIMS)

Application Outlook (Revenue, USD Billion, 2018 - 2030)

• Regenerative Medicine

o Cell Therapy

o Gene Therapy

o Others

• Bio-banking

o Human Eggs

o Human Sperms

o Veterinary IVF

• Drug Discovery

Regional Outlook (Revenue, USD Billion, 2018 - 2030)

• North America

o U.S.

o Canada

• Europe

o Germany

o U.K.

o France

o Italy

o Spain

o Denmark

o Sweden

o Norway

• Asia Pacific

o China

o Japan

o India

o Australia

o Thailand

o South Korea

• Latin America

o Brazil

o Mexico

o Argentina

• Middle East and Africa (MEA)

o South Africa

o Saudi Arabia

o UAE

o Kuwait

Browse through Grand View Research's Biotechnology Industry Research Reports.

• The global optical genome mapping market size was valued at USD 104.1 million in 2023 and is expected to grow at a CAGR of 26.76% from 2024 to 2030. 

• The global therapeutic drug monitoring market size was valued USD 1.80 billion in 2023 and is projected to grow at a CAGR of 3.8% from 2024 to 2030. 

Key Companies & Market Share Insights

Key players in the market are opting for strategic initiatives, funding facilities for geographical expansion, partnerships, mergers and acquisitions in key regions. For instance, in January 2023, the Hamad Medical Corporation and Qatar BioBank launched a new tissue biobank service in Qatar to provide researchers the access to high-quality tissue samples. Some of the key players in the biopreservation market include:

• Azenta US, Inc.

• Biomatrica, Inc.

• BioLife Solutions

• MVE Biological Solutions

• LabVantage Solutions, Inc.

• Taylor-Wharton.

• Thermo Fisher Scientific, Inc.

• Panasonic Corporation

• X-Therma Inc.

• PrincetonCryo.

• Stirling Ultracold 

Order a free sample PDF of the Biopreservation Market Intelligence Study, published by Grand View Research.

[gynogen1]

Best Gynae PCD Company For Pharma Franchise Business

According to research, the Market value of Gynae medicine in India was USD 1.9 billion in 2020 and is expected to increase a CAGR of 12.1% from 2021 to 2028. As per the data you can see there is a good scope for investing in Infertility and Gynae medicines.

if you are looking forward to investing money in the Gynae PCD Pharma franchise business and searching for the best Gynae PCD Pharma Company in India, then Gynogen is the best option. Gynogen is an ISO Certified Gynae Company in India that offers superior-quality Infertility and gynae medicine at a reasonable. 

A Prominent Gynae PCD Pharma Company in India | Gynogen 

With more than 25 years of experience, Gynogen is a reputed PCD Pharma Franchise company for Gynae products for women’s health. The company has a wide range of gynecology, IVF/UGR, and women's health medicines at genuine rates.

Our products help to treat various women’s diseases like hormonal management, fibroids, menstrual disorders/PCOS/PCOD, contraception, etc. Gynogen deals in exporting, trading, and distributing top-quality gynae-related products to fulfill the increasing demand of the market. 

Our company is an ISO-certified pharmaceutical company in all parts of India.

Our products are well tested by our special team to handle quality.

We help you in the advertising and marketing of the company.

The company follows the rules of WHO and GMP.

We use the latest and most modern equipment in our plant.

Our R&D team has a lot of experience in gynecology and pharmacutical.

We give the on-time delivery of all orders with safe packaging.

High Effective Gynae Products Offers by Us With DCGI Approval

Being a top Gynae PCD Pharma Company in India, Gynogen deals in highly effective gynecology medicines that are manufactured with natural and pure raw materials. Our Infertility Products List in India is safe to use for every woman without the risk of any side effects. We believe in customer satisfaction so before delivery we test all medicine in our special laboratory. Here is a list of categories of products that provide us for the Pharma Franchise Business.

Hydramnios 

Contraception 

Infertility/IVF/ugr 

Hormone Imbalance 

Fibroids

Antispasmodic 

Menstruation/PCOS/PCOD 

Menopause

Pregnancy/lactation 

Antifungal/Antibacterial 

Nutritional Supplements

Why Gynogen is the First Choice for Pharma Franchise Business in India

Gynogen is a trusted Gynecology PCD Pharma Franchise company in India that gives the best Franchise services for starting the pharma business. Our company provides full support to our pharma investors with Franchise support, market support, financial support, monopod rights, promotional tools, and more. We have a mission to give high-quality gynae medicine to the entire country at low prices. Here are some benefits of collaborating with Gynogen.

Delivery: We have a strong network in the country so all orders are delivered at the guaranteed time.

Storage: We have a warehouse to store the manufactured products before delivery to maintain the quality of the drug.

Our R&D team: The company appoints a highly skilled and experienced R&D team who focus the innovative formulation.

Quality Assurance: All products are approved with 100% pure raw material that helps to control the quality. 

Contact Details: 

Name: Gynogen 

Address: Tower plot-235D, Rentalk, 8B, Phase 8B, Industrial Area, Sector 74, Zirakpur, Sahibzada Ajit Singh Nagar, Punjab 140603 

Call: +91-9988899209 

Email: klifesciences1991@gmail.com 

[wellnessweb]

Biopreservation Market Size: Key Drivers and Forecasts

The Biopreservation Market size was estimated USD 2.2 billion in 2022 and is expected to reach USD 16.2 billion by 2030 at a CAGR of 28.4% during the forecast period of 2023-2030. The biopreservation market is experiencing rapid growth, driven by advances in biotechnology and increasing demand for personalized medicine. This sector focuses on the preservation of biological samples such as cells, tissues, and organs, utilizing cutting-edge techniques like cryopreservation and vitrification to maintain their viability for extended periods. As the need for reliable storage solutions in biobanking, regenerative medicine, and drug discovery intensifies, companies are innovating with novel cryoprotectants and automated preservation systems. The rise in chronic diseases and the growing emphasis on research and development further propel this market, positioning it as a crucial component in the future of medical and scientific advancements.

Get Sample of This Report @ https://www.snsinsider.com/sample-request/3792

Market Scope & Overview

The report's extensive criteria include an analysis of the leading companies in the market, a study of the knowledge market share, an analysis of the organization's main business lines, product offering, and cost structure, as well as an analysis of current market trends and patterns. In order to research and understand the Biopreservation industry, reliable information sources were used in the examination.

The global market is defined and classified by the market research, which also analyses and foresees regional and global market opportunities. Along with market drivers and restraints, trends, opportunities, and challenges are explored as well. In addition to estimating market quantities for significant categories and geographic regions, the goal of the Biopreservation Market study is to forecast trends and trends for the upcoming years.

Market Segmentation Analysis

By Product

Equipment

Freezers

Refrigerators

Consumables

Vials

Straws

Microtiter Plates

Bags

Liquid Nitrogen

Media

Pre-formulated

Home-brew

Laboratory Information Management System

By Application

Regenerative Medicine

Cell Therapy

Gene Therapy

Others

Bio-banking

Human Eggs

Human Sperms

Veterinary IVF

Drug Discovery

COVID-19 Impact Analysis

Market participants will benefit from the COVID-19 impact study as they develop pandemic preparation plans. The research used both primary and secondary sources of data, in addition to private databases and a paid data source. In this study, the effect of COVID-19 on the Biopreservation Market is examined both globally and domestically. This research considers the indirect effects of the target market on supply and demand.

Regional Outlook

The research focuses on recently developing regional marketplaces where business owners in the industry can find their next venture. The most recent Biopreservation Market study focuses on Asia Pacific, North America, Latin America, Europe, and the Middle East and Africa while also looking closely at other geographical regions.

Competitive Analysis

An overview of the industry, including its definition, uses, and manufacturing processes, is provided in the research report's opening section. The research report then explores the significant players in the global sector. With a focus on the target market, the research study offers an in-depth and thorough examination of the current condition of the Biopreservation Market business. The study contains a substantial amount of market data, making it a valuable resource for businesses and individuals with an interest in the sector.

Key Questions Answered by the Biopreservation Market Report

What global occurrences have influenced the market's expansion as a whole?

What are the most recent developments of the key market participants?

What effects has the conflict between Russia and Ukraine had on the dynamics of the target market?

Conclusion

The Biopreservation Market research report will act as primary tool for market participants and other stakeholders to get complete hold over the market dynamics and device their strategies accordingly.

Read Full Report @ https://www.snsinsider.com/reports/biopreservation-market-3792

About Us

SNS Insider is a market research and insights firm that has won several awards and earned a solid reputation for service and strategy. We are a strategic partner who can assist you in reframing issues and generating answers to the trickiest business difficulties. For greater consumer insight and client experiences, we leverage the power of experience and people.

When you employ our services, you will collaborate with qualified and experienced staff. We believe it is crucial to collaborate with our clients to ensure that each project is customized to meet their demands. Nobody knows your customers or community better than you do. Therefore, our team needs to ask the correct questions that appeal to your audience in order to collect the best information.

Related Reports

Forensic Technology Industry Trends

Functional Service Providers Industry Trends

Genome Editing Industry Trends

Genomics Services Industry Trends

Genotyping Industry Trends

[yathermscientific]

CO2 Incubator Troubleshooting: Common Problems and Solutions

Is your CO2 incubator giving you trouble? Check out this guide for common problems and solutions to keep your experiments running smoothly.

A CO2 incubator is a crucial piece of equipment for many scientific experiments, but it can be frustrating when it's not working properly. This guide will help you troubleshoot common issues with your CO2 incubator and provide solutions to keep your experiments running smoothly.

Temperature fluctuations

One common problem with CO2 incubators is temperature fluctuations. This can be caused by a variety of factors, including a malfunctioning thermostat, a faulty heating element, or poor insulation. To troubleshoot this issue, first check the thermostat and make sure it is set to the correct temperature. If the thermostat is working properly, check the heating element and make sure it is functioning correctly. If neither of these solutions work, it may be necessary to replace the insulation or contact a professional for further assistance.

CO2 level fluctuations

Another common problem with CO2 incubators is fluctuations in CO2 levels. This can be caused by a variety of factors, including a malfunctioning CO2 sensor, a clogged gas inlet, or a leak in the system. To troubleshoot this issue, first check the CO2 sensor and make sure it is functioning properly. If the sensor is working correctly, check the gas inlet and make sure it is not clogged. If neither of these solutions work, it may be necessary to check for leaks in the system or contact a professional for further assistance.

Contamination

Contamination is a common problem in CO2 incubators and can be caused by a variety of factors, including improper cleaning, contaminated media or reagents, or a malfunctioning HEPA filter. To prevent contamination, it is important to regularly clean and disinfect the incubator and all equipment used inside. Additionally, make sure to use sterile media and reagents and regularly replace the HEPA filter. If contamination does occur, it may be necessary to discard any affected samples and thoroughly clean the incubator before starting again.

Read more: Co2 Incubator-About, Benefits & Where to Buy

Water accumulation

Water accumulation is a common problem in CO2 incubators and can be caused by a variety of factors, including condensation from high humidity levels or a malfunctioning water pan or drain. To prevent water accumulation, make sure to regularly check and empty the water pan and ensure that the drain is functioning properly. Additionally, reducing the humidity levels in the incubator can help prevent condensation. If water accumulation does occur, it is important to thoroughly clean and disinfect the affected areas to prevent contamination.

Door seal issues

One common problem with CO2 incubators is door seal issues. If the door seal is not functioning properly, it can lead to temperature and humidity fluctuations, which can negatively impact your experiments. To check for door seal issues, inspect the seal for any cracks or gaps. If you notice any issues, try cleaning the seal with a mild detergent and warm water. If the problem persists, you may need to replace the seal. It is important to address door seal issues promptly to ensure the integrity of your experiments.

[dssima]

Impactful Role in the Evolution of Medical Technology at DSS Imagetech

In the dynamic world of medical technology, DSS Imagetech emerged as a pioneering force, driving transformative change and innovation. With a steadfast commitment to excellence, DSS Imagetech has played a pivotal role in advancing medical imaging, diagnostics, and life sciences. This article delves into the key contributions and impactful initiatives that define DSS Imagetech's journey in the evolution of medical technology.From its early days as a family-owned business to its current stature, the company has played a pivotal role in shaping the revolution of medical imaging, clinical diagnostics, and research and development.

Inspired by Updated Technology:

At the core of DSS Imagetech's mission is a deep inspiration drawn from cutting-edge technology. This driving force fuels the company's dedication to providing state-of-the-art solutions to researchers and clinicians in the fields of life sciences and healthcare.

75 Years of Innovation:

DSS Imagetech's legacy spans an impressive 75 years, marked by a consistent pursuit of innovation. From its humble beginnings to becoming a recognized leader, the company's journey reflects a rich history of adapting to technological advancements. DSS Imagetech has been established in more than 13+ cities with 150 people in each branch. While DSS’ product portfolio encompasses a wide range of products for Life Sciences research, Medical Diagnostics and Healthcare we currently maintain our focus on Research Imaging, Clinical Diagnostics, IVF and Food Testing. With our vast experience and expertise and qualified team we readily bring solutions in these fields to the Indian scientific & medical fraternity through manufacturing, distribution and innovation. 

Comprehensive Solutions Across Divisions

DSS Imagetech's influence extends across Micro-Imaging, Clinical Diagnostics, Medical Equipment, and Research & Development. By maintaining a diversified portfolio, the company addresses the varied needs of the scientific and medical fraternity.

Strategic Infrastructure and Presence

With a factory and corporate office in Noida/New Delhi, branch offices in major cities, and representative offices in principal cities across India, DSS Imagetech has strategically positioned itself to provide comprehensive support and solutions nationwide.

Marketing Infrastructure and Global Alliances

The company's robust marketing infrastructure, coupled with a distribution network for world-leading brands, reflects its commitment to bringing the latest technologies to its customers. DSS Imagetech's international alliances contribute to its status as a global player.With offices in 13+ cities and a 150-people strong team, DSS Imagetech has become a distributor for some of the world’s leading brands in the industry. It has brought to its customers the latest and most relevant technologies with their specific needs. 

In Focus Technologies

DSS Imagetech's focus on Research Imaging, Clinical Diagnostics, IVF, and Food Testing demonstrates its adaptability to evolving scientific demands, all type of medical produst manufacutrers services. The company's expertise and experience shine through as it continues to provide advanced solutions to the scientific community.

Partnerships with Renowned Institutions:

Collaborating with leading research and educational institutes, pharmaceutical, and biotech industries, DSS Imagetech actively contributes to advancements in Life Science research. The company's involvement with institutions like the Indian Institute of Science underlines its commitment to driving impactful research. Our company has a feautres of collabration with other popular brand with DSS Imagetech

International Recognition and Alliances

DSS Imagetech's recognition as a DST/DSIR-recognized R&D centre and its long-standing international alliances underscore its global standing. These alliances contribute not only to the company's growth but also to the exchange of knowledge and expertise on a global scale.

Conclusion

In conclusion, DSS Imagetech's impactful role in the evolution of medical technology is evident through its rich history, diversified portfolio, strategic infrastructure, and commitment to innovation. As the medical products company continues to inspire change and push the boundaries of what is possible in healthcare and life sciences, its journey serves as a beacon in the ever-evolving landscape of medical technology.

[modular-hospital-equipment]

Modular Operation Theatre represents the latest trend in Operation Theatres, where cleanliness and sterility are maintained at all time. Modular prefabricated panel, antibacterial flooring, Laminar flow units, HEPA filters and air handling units are used to achieve sterilization. Altos Engineers is the Modular Operation Theatre Manufacturer of India

Altos Engineers have vast experience in Modular Operation Theater design and installation following NABH guidelines. We provide Modular Operation Theater products of the highest quality at reasonable prices, and we deliver on time. Our group of experienced design engineers are able to understand client requirements and deliver the best designs according to site conditions.

Our state-of-the-art facility is equipped to manufacture the products and accessories for operation theatre construction. Our Laminar Flow Units are made of robust materials and have a high-quality finish. Our products are made with precision using imported machinery. Every corner of our theatre is designed to be easily cleaned.

Altos Engineers provides modular operation theatres for various surgeries such as Liver & Kidney Transplants, Knee Replacement, Cardio Thoracic, General Surgery, Other Super Specialties, and other general surgeries.

Altos Engineers, Modular Operation Theater manufacturer and supplier in India. We offer complete turnkey solutions to modular operation theatres as per the most recent guidelines. In operation theatres, air conditioning systems are vital in maintaining sterility and cleanliness.

The modular operation theatre in a hospital is where the surgical procedures are performed under sterile conditions. Altos Engineers is the modular operation theatre manufacturer in india.

We can also design ICUs, positive pressure and negative pressure rooms to suit different post-operative patients.

We provide the best quality:

Modular Operation Theater

Isolation rooms

IVF Labs

BMT Rooms

Modular Operation Theatre Features

The Good and State of the Art Modular operating room construction.

Low Noise

Easy to clean

Long Life

Highly Durable

Modular Operation Theater Accessories:

Modular Pendants

Modular Well & Ceiling Panels

Modular Laminar Air Flow

Modular Hatch Box

Modular Peripheral light

Modular X-Ray Board

Modular Surgeon Control Panel

Writing Board

Modular Operation Theatre Surgical LED Light

Modular OT Door

Modular Pressure Relief Damper

Modular Scrub Sinks

Complete Modular Operation Theatre Setup

[drforambhuta]

IVF, or in vitro fertilization, has both positive and negative impacts on individuals and society. Let's explore some of the main ways in which IVF has affected us:

Benefits of IVF:

Parenthood is More Accessible: IVF has opened up the possibility of parenthood to couples who struggle with infertility. Same-sex couples and single parents can also use IVF to have a child. This technology gives hope to those who previously thought they could never conceive.

Advances in Medical Science: IVF has led to significant progress in reproductive medicine. The technology used in IVF has deepened our understanding of the biology of reproduction and has facilitated the treatment of infertility and other reproductive disorders.

Economic Benefits: IVF is a thriving industry that creates jobs and contributes to economic growth. IVF clinics and hospitals, equipment manufacturers, and tourism all generate revenue and jobs. Couples travel to different countries for fertility treatments, stimulating economic activity in various regions.

Improved Success Rates: Over time, IVF technology has improved, leading to higher success rates. More couples are now able to conceive and give birth to healthy babies, raising the hope of achieving parenthood.

Drawbacks of IVF:

Financial Burden: IVF can be costly, with fees ranging from INR 1,50,000 to INR 4,00,000 per cycle. Many insurance companies do not cover IVF, which makes it challenging for couples to afford treatment. As a result, there is an economic disparity in accessing IVF services.

Ethical Issues: IVF raises ethical concerns related to the creation and use of embryos. Some individuals consider creating embryos in a laboratory morally wrong. Additionally, there are questions about the destiny of unused embryos. Embryo screening, which allows parents to select embryos based on genetic traits, is also a controversial topic.

Risk of Multiple Pregnancies: IVF increases the chances of multiple pregnancies, which can be risky for both the mother and the babies. Multiple pregnancies are more likely to result in premature birth, low birth weight, and other health issues. This can put pressure on healthcare systems and cause emotional and financial stress for parents.

Emotional Toll: IVF can be an emotional and stressful experience for couples. Failed cycles, financial burdens, and the uncertainty of success can impact a couple's mental health. The pressure to conceive can strain relationships and make it difficult to navigate the journey towards parenthood.

Overall, IVF has had a significant impact on individuals and society, providing hope and progress in reproductive medicine while also presenting financial, ethical, and emotional challenges.

To get good results, you can contact the best IVF doctor in Mumbai. IVF treatment in Mumbai has a high rate of success and minimal possibility of developing complications.

[seletivf1234]

Cost of IVF in Sierra Leone

In vitro fertilization (IVF) is a medical procedure that helps couples who are struggling with infertility to conceive a child. IVF involves the fertilization of an egg outside of the woman’s body in a laboratory, and then the embryo is transferred back into the woman’s uterus. This procedure has been successful in helping many couples to have a child, but it can also be quite expensive. In Sierra Leone, where the cost of living is already high, the cost of IVF can be prohibitive for many couples.

The cost of IVF in Sierra Leone varies depending on the clinic and the specific treatment plan. On average, the cost of one cycle of IVF in Sierra Leone can range from $7,000 to $15,000. This cost includes the initial consultation, the medications needed for the procedure, the egg retrieval process, and the embryo transfer. However, it is important to note that this cost does not include additional procedures that may be required, such as intracytoplasmic sperm injection (ICSI), which is used when the man’s sperm count is low. ICSI can cost an additional $1,000 to $2,000 per cycle.

The high cost of IVF in Sierra Leone is due to several factors. First, the cost of medical supplies and equipment is high. The country does not have a strong manufacturing industry, so most medical supplies and equipment must be imported from other countries. This makes the cost of these items much higher than it would be in a country with a strong manufacturing industry.

Second, the cost of labor is also high in Sierra Leone. Medical professionals such as doctors, nurses, and laboratory technicians require specialized training and education, and their salaries reflect this. Additionally, the demand for medical services in Sierra Leone is high, which means that these professionals can charge higher fees for their services.

Third, the lack of insurance coverage for IVF in Sierra Leone means that couples must pay for the procedure out of pocket. There are no government programs or private insurance plans that cover the cost of IVF in Sierra Leone, which means that couples must rely on their own savings or take out loans to pay for the procedure.

The high cost of IVF in Sierra Leone means that many couples who would benefit from the procedure are unable to afford it. This can be devastating for couples who have already been struggling with infertility for years. The emotional toll of infertility is already high, and the added stress of not being able to afford IVF can be overwhelming.

There are some options for couples who are unable to afford IVF in Sierra Leone. One option is to explore medical tourism. This involves traveling to another country where the cost of IVF is lower. However, this option comes with its own risks and challenges, such as navigating a foreign healthcare system and the cost of travel and accommodations.

Another option is to explore alternative forms of fertility treatment. These can include treatments such as acupuncture, herbal remedies, and lifestyle changes. While these treatments may not be as effective as IVF, they can be a more affordable option for couples who are unable to afford the high cost of IVF.

Finally, couples can explore adoption as an alternative to IVF. While adoption can also be a costly and complicated process, it can provide a path to parenthood for couples who are unable to conceive a child through IVF.

In conclusion, the cost of IVF in Sierra Leone is prohibitively high for many couples. The high cost is due to a variety of factors, including the cost of medical supplies and equipment, the high cost of labor, and the lack of insurance coverage for the procedure. While there are some options for couples who are unable to afford IVF, such as medical tourism, alternative forms of fertility treatment, and adoption, these options may not be as effective or feasible.

[imaec-digital]

Cidaltek ID-50

Salient Features:

Aldehyde- free, disinfects tools rapidly

Triamine based technology

Eco-friendly

Highly effective

Provides excellent anti-microbial efficacy

Excellent compatibility with RO membrane

Lubricant for instruments

Good surface-active properties

High efficacy even in the presence of heavy organic soiling, such as protein or blood

Best choice for Urological medical device disinfection • Broad-spectrum microbial efficacy

Active against Tb and specific viruses (e.g., Hepatitis-B)

Sporicidal in action

Excellent material compatibility

Best option for Cancer hospital, IVF centres, Obstetrics and Gynaecology centres, Orthopaedic centres, Opthal Clinics, Paediatric Hospitals

Contact Time: • For Pre-Cleaning of instruments: – 2% solution for 15 min • For Instrument Disinfection: – 2% solution for 60 min • For RO Membrane Disinfection: 2% solution for 30-45 mins

Direction Of Use:

How to Use:

For Instruments, Tools, equipment’s, Utensil Precleaning & Disinfection 

For Pre-cleaning heat sensitive semi-critical medical device such as Endoscope, cystoscope etc, Surgical Instruments / equipment submerse them into Cidaltek -ID 50 2% solution for minimum 15 min.

Remove heavy soil/organic deposits from surface.

Rinse thoroughly with tap water (hardness less than 400 ppm).

For other pre-cleaning agents, refer to surgical instruments/equipment manufacturers recommendations.

For disinfection, submerse clean instrument/equipment in Cidaltek -ID 50 2% solution for 60 min according to the requirement.

Rinse with sterile distilled water and allow to dry before use.

Prepare a fresh solution daily or more often if the solution become visibly dirty or diluted then discard it.

Area Of Application:

1) In Hospitals:

Heat sensitive instrument cleaning, pre-cleaning and disinfection of surgical tools & instruments in pharmaceutical, hospital, medical colleges, laboratories, etc.

2) In Veterinary Clinics:

Heat sensitive surgical instrument, tools & SS grade surgical instruments for precleaning & disinfection

3) In Dairy & Food industries :

For precleaning and disinfection of milk containers, milk processing units, milking machines, Storage tanks, Fermenters, milk carrier vehicles, packaging units, flushing of pipelines, RO membrane disinfection etc.

4) Wine & Brewery industries :

For precleaning and disinfection of Grapes & grains storage containers, fermenters, Carrier pipelines, barrels, RO membrane disinfection etc.

5) Poultry/Hatcheries centres/Fisheries/Meat & processing units :

Cutting & processing instruments, storage containers, Mixing units, various handling instruments, etc.

6) Pharmaceutical /Vaccine manufacturing/Research labs :

For precleaning and disinfection of heat sensitive equipment’s/instruments, RO membrane disinfection etc.

Microbial Efficacy:

Bactericidal, Fungicidal, Yeasticidal, Virucidal & Sporicidal.  

[healthcare-domain]

Infertility Treatment Market Size, Share | 2026 | MarketsandMarkets

According to the new market research report "Infertility Treatment Market by Product (Equipment, Media, Accessories), Procedure (ART (IVF,ICSI, Surrogate), Insemination, Laparoscopy, Hysteroscopy, Patient Type (Female, Male), End User (Fertility Clinics, Hospitals, Research) - Global Forecast to 2026", published by MarketsandMarkets™, the global Infertility Treatment Market size is projected to reach USD 2.2 billion by 2026 from USD 1.5 billion in 2021, at a CAGR of 8.1% during the forecast period.

The decline in the fertility rate, increase awareness about the availability of infertility treatment procedures, rising number of fertility clinics, increasing public & private investments and growing technological advancements are expected to drive market growth in the coming years

The infertility treatment market include major Tier I and II suppliers of infertility treatment equipment, media & consumables are The Cooper Companies Inc. (US), Cook Group (US), Vitrolife (Sweden), Thermo Fisher Scientific, Inc. (US), Esco Micro Pte. Ltd. (Singapore), Genea Biomedx (Australia), IVFtech ApS (Denmark), FUJIFILM Irvine Scientific (US), The Baker Company, Inc. (US), Kitazato Corporation (Japan), Rocket Medical plc (UK), IHMedical A/S (Denmark), Hamilton Thorne Ltd. (US), ZEISS Group (Germany), MedGyn Products, Inc. (US), DxNow, Inc. (US), Nidacon International AB (Sweden), Gynotec B.V. (Netherlands), SAR Healthline Pvt. Ltd. (India), and InVitroCare Inc. (US). These suppliers have their manufacturing facilities spread across regions such as North America, Europe, Asia Pacific.

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=43497112

COVID-19 has impacted their businesses as well. Logistical issues, managing patients with the disease, prioritizing patients with comorbidities and pre-existing conditions, and protecting public & hospital frontline workers from exposure to the COVID-19 infection are the major challenges faced by healthcare systems across the globe. One in six reproductive-aged couples experiences infertility, and many turn to treatments such as intrauterine insemination (IUI) and in vitro fertilization (IVF), which require in-person appointments to complete. In India, 30 lakh people seek infertility treatment every year, but only 5 lakh people undergo IVF/intrauterine insemination (IUI) procedures. During the COVID-19 pandemic, a 90% drop was observed in the number of people undergoing IVF cycles. The spread of COVID-19 has not only impacted fertility clinics owing to the cancellation of IVF treatments but has also impacted fertility decisions among couples who were opting for IVF treatment before the pandemic.

The rise in number of fertility clinics to support the market growth during the forecast period.

Significant rise in number of fertility clinics, coupled with the decline in the fertility rate across the globe. Along with this growing focus of players and government towards the launching and acquiring new fertility centers across the globe is likely to contribute towards the growth of the segment. The expansion of fertility clinics equipped with advanced technology is anticipated to increase the accessibility of infertility treatment devices among infertile couples.

Speak to Analyst: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=43497112

Asia Pacific likely to emerge as the fastest-growing infertility treatment market, globally

Geographically, the emerging Asian countries, such as China, India, Japan and Singapore, are offering high-growth opportunities for market players. The Asia Pacific point of care market is projected to grow at the highest CAGR of 9.1% from 2021 to 2026. Expansion of healthcare infrastructure and increase in disposable personal income, rising medical tourism in Asian countries, increasing healthcare expenditure, and growing awareness among people about infertility are supporting the growth of the infertility treatment market in the region.

Prominent players in this market are The Cooper Companies Inc. (US), Cook Group (US), Vitrolife (Sweden), Thermo Fisher Scientific, Inc. (US), FUJIFILM Irvine Scientific (US), Kitazato Corporation (Japan), and Hamilton Thorne Ltd. (US).

[hospitalproductd]

IVF Equipment Suppliers, Manufacturers, & Dealers contact details are available on the Hospital Product Directory. Also check out our website for medical equipment, healthcare services & product. Visit HPD for IVF Equipment Manufacturers, Suppliers, & Dealers in India.

[esglatestmarketnews]

In-vitro Fertilization Microscopes Market Growth Prospects And Industry Growth Rate 2022-2030

The rising prevalence of infertility among men and women is expected to foster the growth of the market for IVF microscopes during the forecast period.

The global in-vitro fertilization microscopes market size is expected to reach USD 193.2 million by 2030, according to a new report by Grand View Research. The market is expected to expand at a CAGR of 8.4% from 2022 to 2030. The market has witnessed advancements in microscopes and microscope-related equipment for use in in-vitro fertilization. Artificial Intelligence (AI), embryo assessment, and sperm selection are some of the applications targeted for innovation.

Manufacturers are providing upright microscopes, digital microscope cameras, and software to view images together as a sperm analysis system to provide the complete solution for semen analysis. Moreover, as sperm analysis can be better studied by maintaining a certain temperature of the sample, manufacturers are coupling the use of such devices along with an upright microscope. For instance, PROiSER provides ISAS HEAT, a slide warmer, compatible with its UB200i upright microscope used along with Computer Assisted Semen Analysis (CASA) systems.

The demand for In-vitro Fertilization (IVF) procedures is now increasing due to the relaxation of travel restrictions and supporting government guidelines. For instance, the American Society of Reproductive Medicine (ASRM) announced that there is a need to ensure reproductive care with maximal safety as we will have to continue to live with a COVID-19.

In-vitro Fertilization Microscopes Market Report Highlights

• Based on the end-use, the clinical segment dominated the market in 2021 in terms of revenue. IVF clinics provide a range of services, including healthy oocyte identification, semen analysis, ICSI, embryo monitoring, and freezing and storage of embryos

• The clinical segment is also expected to witness the fastest growth from 2022 to 2030 due to the increasing adoption of IVF treatment. Moreover, manufacturers are developing innovative products with integrated technologies, such as Artificial Intelligence (AI)

• Europe held the largest share in terms of revenue in 2021 due to factors such as the high cost of IVF treatment and the availability of reimbursement. The Asia Pacific region is expected to witness the fastest growth from 2022 to 2030 due to the initiatives to create awareness regarding IVF treatment in countries such as India

• The IVF microscopes market is saturated with many prominent players. The companies operating in the market are adopting various strategies such as product innovation, market expansion, and introduction of advanced technology to stay competitive in the market

• For instance, in February 2019, Opto GmbH debuted the DualStation embryo imaging microscope. The DualStation is designed to provide all the optical techniques and imaging requirements used by IVF processes into a single enclosed embryo chamber

The global life science microscopes industry generated over USD 3.36 billion in 2021 and is expected to grow at a CAGR of 8.9% over the forecast period. 

In-vitro Fertilization Microscopes Market Segmentation

Grand View Research has segmented the global in-vitro fertilization microscopes market on the basis of end-use and region:

In-vitro Fertilization Microscopes End-use Outlook (Revenue, USD Million, 2017 – 2030)

• Clinical

• Academic Research

In-vitro Fertilization Microscopes Regional Outlook (Revenue, USD Million, 2017 – 2030)

• North America

    o U.S.

   o Canada

• Europe

   o Germany

   o U.K.

   o France

   o Italy

   o Spain

• Asia Pacific

   o Japan

   o China

   o India

• Latin America

   o Brazil

   o Mexico

• Middle East & Africa (MEA)

   o South Africa

List of Key Players in the In-vitro Fertilization Microscopes Market

• Linkam Scientific Instruments

• Olympus Corporation

• Leica Microsystems

• Meiji Techno

• Zeiss

• Euromex Microscopen B.V.

• Labomed Europe B.V.

• Nikon Corporation

• Narishige Group

• Eppendorf AG

• Hamilton Thorne Ltd.

• Sutter Instrument Company

• Tritech Research, Inc.

Request free sample copy of Life Science Microscopes Industry Data Book @ https://www.grandviewresearch.com/sector-report/life-science-microscopes-industry-data-book/request/rs